Initia is proud to announce an important regulatory milestone: MORENOVA PRO and MORENOVA DT have received UKCA approval as Class IIa medical devices, with Intertek serving as the UK Approved Body.

This achievement marks another important step in Initia’s international expansion and reflects the company’s continued commitment to advancing innovative Low-Intensity Shockwave Therapy (LiSWT) solutions for healthcare professionals in global markets.

Advancing MORENOVA in the UK Market

UKCA approval supports the continued introduction of MORENOVA PRO and MORENOVA DT in the UK and strengthens Initia’s regulatory foundation for further market development.

Both systems form part of a versatile shockwave technology platform with medical applications across Men’s Health, Women’s Health, and Musculoskeletal care. The devices may also be used for aesthetic purposes, further broadening their potential range of applications.

Supporting International Growth

This milestone reinforces Initia’s broader strategy to expand access to advanced shockwave technology and support healthcare professionals with flexible, clinically relevant solutions across multiple fields of medicine.

For the Initia team, the UKCA approval of MORENOVA PRO and MORENOVA DT represents another important achievement in the company’s continued international growth and an exciting step forward in strengthening the MORENOVA platform’s presence in the UK market.